201 related articles for article (PubMed ID: 35985342)
21. Brain pyrimidine nucleotide synthesis and Alzheimer disease.
Pesini A; Iglesias E; Bayona-Bafaluy MP; Garrido-Pérez N; Meade P; Gaudó P; Jiménez-Salvador I; Andrés-Benito P; Montoya J; Ferrer I; Pesini P; Ruiz-Pesini E
Aging (Albany NY); 2019 Sep; 11(19):8433-8462. PubMed ID: 31560653
[TBL] [Abstract][Full Text] [Related]
22. [Diffuse midline glioma].
Saito R
No Shinkei Geka; 2022 Jan; 50(1):29-38. PubMed ID: 35169084
[TBL] [Abstract][Full Text] [Related]
23. Pyrimidine metabolism in Giardia lamblia trophozoites.
Lindmark DG; Jarroll EL
Mol Biochem Parasitol; 1982 May; 5(5):291-6. PubMed ID: 7099205
[TBL] [Abstract][Full Text] [Related]
24. STAT3 is a biologically relevant therapeutic target in H3K27M-mutant diffuse midline glioma.
Zhang L; Nesvick CL; Day CA; Choi J; Lu VM; Peterson T; Power EA; Anderson JB; Hamdan FH; Decker PA; Simons R; Welby JP; Siada R; Ge J; Kaptzan T; Johnsen SA; Hinchcliffe EH; Daniels DJ
Neuro Oncol; 2022 Oct; 24(10):1700-1711. PubMed ID: 35397475
[TBL] [Abstract][Full Text] [Related]
25. Pyrimidine metabolism in Tritrichomonas foetus.
Jarroll EL; Lindmark DG; Paolella P
J Parasitol; 1983 Oct; 69(5):846-9. PubMed ID: 6200591
[TBL] [Abstract][Full Text] [Related]
26. Cancer-selective metabolic vulnerabilities in MYC-amplified medulloblastoma.
Gwynne WD; Suk Y; Custers S; Mikolajewicz N; Chan JK; Zador Z; Chafe SC; Zhai K; Escudero L; Zhang C; Zaslaver O; Chokshi C; Shaikh MV; Bakhshinyan D; Burns I; Chaudhry I; Nachmani O; Mobilio D; Maich WT; Mero P; Brown KR; Quaile AT; Venugopal C; Moffat J; Montenegro-Burke JR; Singh SK
Cancer Cell; 2022 Dec; 40(12):1488-1502.e7. PubMed ID: 36368321
[TBL] [Abstract][Full Text] [Related]
27. Venetoclax Cooperates with Ionizing Radiation to Attenuate Diffuse Midline Glioma Tumor Growth.
Madhavan K; Balakrishnan I; Lakshmanachetty S; Pierce A; Sanford B; Fosmire S; Elajaili HB; Walker F; Wang D; Nozik ES; Mitra SS; Dahl NA; Vibhakar R; Venkataraman S
Clin Cancer Res; 2022 Jun; 28(11):2409-2424. PubMed ID: 35344040
[TBL] [Abstract][Full Text] [Related]
28. Alteration in de novo pyrimidine biosynthesis during uridine reversal of pyrazofurin-inhibited DNA synthesis.
Ringer DP; Howell BA; Etheredge JL
J Biochem Toxicol; 1991; 6(1):19-27. PubMed ID: 1880786
[TBL] [Abstract][Full Text] [Related]
29. Genetic dissection of pyrimidine biosynthesis and salvage in Leishmania donovani.
Wilson ZN; Gilroy CA; Boitz JM; Ullman B; Yates PA
J Biol Chem; 2012 Apr; 287(16):12759-70. PubMed ID: 22367196
[TBL] [Abstract][Full Text] [Related]
30. Effective deploying of a novel DHODH inhibitor against herpes simplex type 1 and type 2 replication.
Luganini A; Sibille G; Mognetti B; Sainas S; Pippione AC; Giorgis M; Boschi D; Lolli ML; Gribaudo G
Antiviral Res; 2021 May; 189():105057. PubMed ID: 33716051
[TBL] [Abstract][Full Text] [Related]
31. Effect of inhibitors of the de novo pyrimidine biosynthetic pathway on serum uridine levels in mice.
Karle JM; Anderson LW; Dietrick DD; Cysyk RL
Cancer Res; 1981 Dec; 41(12 Pt 1):4952-5. PubMed ID: 6171344
[TBL] [Abstract][Full Text] [Related]
32. Revisiting the role of dihydroorotate dehydrogenase as a therapeutic target for cancer.
Madak JT; Bankhead A; Cuthbertson CR; Showalter HD; Neamati N
Pharmacol Ther; 2019 Mar; 195():111-131. PubMed ID: 30347213
[TBL] [Abstract][Full Text] [Related]
33. Revealing de novo pyrimidine synthesis as a key vulnerability in brain tumors.
Schild T; Keshari KR
Cancer Cell; 2022 Dec; 40(12):1457-1458. PubMed ID: 36400017
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of the mitochondrial pyrimidine biosynthesis enzyme dihydroorotate dehydrogenase by doxorubicin and brequinar sensitizes cancer cells to TRAIL-induced apoptosis.
He T; Haapa-Paananen S; Kaminskyy VO; Kohonen P; Fey V; Zhivotovsky B; Kallioniemi O; Perälä M
Oncogene; 2014 Jul; 33(27):3538-49. PubMed ID: 24013224
[TBL] [Abstract][Full Text] [Related]
35. Leflunomide inhibits pyrimidine de novo synthesis in mitogen-stimulated T-lymphocytes from healthy humans.
Rückemann K; Fairbanks LD; Carrey EA; Hawrylowicz CM; Richards DF; Kirschbaum B; Simmonds HA
J Biol Chem; 1998 Aug; 273(34):21682-91. PubMed ID: 9705303
[TBL] [Abstract][Full Text] [Related]
36. An ERK5-PFKFB3 axis regulates glycolysis and represents a therapeutic vulnerability in pediatric diffuse midline glioma.
Casillo SM; Gatesman TA; Chilukuri A; Varadharajan S; Johnson BJ; David Premkumar DR; Jane EP; Plute TJ; Koncar RF; Stanton AJ; Biagi-Junior CAO; Barber CS; Halbert ME; Golbourn BJ; Halligan K; Cruz AF; Mansi NM; Cheney A; Mullett SJ; Land CV; Perez JL; Myers MI; Agrawal N; Michel JJ; Chang YF; Vaske OM; MichaelRaj A; Lieberman FS; Felker J; Shiva S; Bertrand KC; Amankulor N; Hadjipanayis CG; Abdullah KG; Zinn PO; Friedlander RM; Abel TJ; Nazarian J; Venneti S; Filbin MG; Gelhaus SL; Mack SC; Pollack IF; Agnihotri S
Cell Rep; 2024 Jan; 43(1):113557. PubMed ID: 38113141
[TBL] [Abstract][Full Text] [Related]
37. Real-time drug testing of paediatric diffuse midline glioma to support clinical decision making: The Zurich DIPG/DMG centre experience.
Mueller T; Laternser S; Guerreiro Stücklin AS; Gerber NU; Mourabit S; Rizo M; Rushing EJ; Kottke R; Grotzer M; Krayenbühl N; Nazarian J; Mueller S
Eur J Cancer; 2023 Jan; 178():171-179. PubMed ID: 36455411
[TBL] [Abstract][Full Text] [Related]
38. Changes in the de novo, salvage, and degradation pathways of pyrimidine nucleotides during tobacco shoot organogenesis.
Loukanina N; Stasolla C; Belmonte MF; Yeung EC; Thorpe TA
Plant Physiol Biochem; 2008 Jul; 46(7):665-672. PubMed ID: 18474429
[TBL] [Abstract][Full Text] [Related]
39. Control of pyrimidine biosynthesis in human lymphocytes. Inhibition of pyrimidine biosynthesis de novo in phytohemagglutinin-stimulated lymphocytes by external uridine and its inhibition mechanism.
Ito K; Uchino H
J Biol Chem; 1973 Jul; 248(13):4782-5. PubMed ID: 4718743
[No Abstract] [Full Text] [Related]
40. A novel CDK4/6 inhibitor combined with irradiation demonstrates potent anti-tumor efficacy in diffuse midline glioma.
Zuo P; Li Y; Wang T; Lin X; Wu Z; Zhang J; Liao X; Zhang L
J Neurooncol; 2023 May; 163(1):159-171. PubMed ID: 37133743
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
